V. Polydoropoulou

A multicentre randomised phase III trial comparing pembrolizumab vs single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial.

U. Dafni, R. Stahel, S. Peters, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project.

A. Warth, A. Marchetti, L. Bubendorf, 2019, Lung cancer.

Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis.

D. Karlis, G. Coukos, U. Dafni, 2019 .

A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

R. Stahel, H. Roschitzki-Voser, E. Nadal, 2019, Annals of Oncology.

Efficacy of Adoptive Therapy with Tumor-infiltrating Lymphocytes and Recombinant Interleukin-2 in Advanced Cutaneous Melanoma: A Systematic Review and Meta-analysis.

D. Karlis, G. Coukos, U. Dafni, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study

M. Dowsett, R. Gelber, D. Larsimont, 2018, Clinical Cancer Research.

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project

A. Warth, A. Marchetti, L. Bubendorf, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

C. Dooms, K. Nackaerts, A. Warth, 2019, Modern Pathology.

Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial.

C. Sotiriou, M. Dowsett, S. Loi, 2016, JAMA oncology.

Evaluation of NGS and RT‐PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project

C. Dooms, K. Nackaerts, A. Warth, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prevalence and clinical correlation of programmed cell death 1 ligand (PD-L1) expression in patients with resected non-small cell lung cancer (NSCLC): Results from the European Thoracic Oncology Platform (ETOP) Lungscape cohort.

A. Warth, A. Marchetti, L. Bubendorf, 2017 .

Exploratory Analysis of Single-Gene Predictive Biomarkers in HERA DASL Cohort Reveals That C8A mRNA Expression Is Prognostic of Outcome and Predictive of Benefit of Trastuzumab

M. Dowsett, D. Karlis, U. Dafni, 2018, JCO precision oncology.